Is Mrna 1345 rna registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 2 valid registrations of Mrna 1345 rna, including mRESVIA (50 µg, Concentrate for dispersion for injection, SAR 867.75).

Active substance

Mrna 1345 rna

SFDA 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
mRESVIA	50 µg	Concentrate for dispersion for injection · Intramuscular use	1 Pre-filled syringe	SAR 867.75	Biological · Prescription	Tabuk Pharmaceutical Manufacturing Company	Valid
mRESVIA	50 µg	Concentrate for dispersion for injection · Intramuscular use	10 Pre-filled syringe	SAR 8677.50	Biological · Prescription	Tabuk Pharmaceutical Manufacturing Company	Valid

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.